VolitionRx receives NYSE American non-compliance notice for stockholders' equity; must submit plan by March 8, 2026

VOLITIONRX LTD

Received NYSE American notice on Feb 6, 2026 for failing $2M, $4M, $6M stockholders' equity thresholds due to sustained losses.
Must submit compliance plan by March 8, 2026; deadline to regain compliance is August 6, 2027.
Stock will trade under VNRX with ".BC" designation indicating "below compliance."
If plan not submitted or accepted, NYSE American will commence delisting proceedings.
No immediate impact on listing or business operations; company intends to submit a plan.

item 3.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.